Purifying stem cell‐derived red blood cells: a high‐throughput label‐free downstream processing strategy based on microfluidic spiral inertial separation and membrane filtration

Cell‐based therapeutics, such as in vitro manufactured red blood cells (mRBCs), are different to traditional biopharmaceutical products (the final product being the cells themselves as opposed to biological molecules such as proteins) and that presents a challenge of developing new robust and econom...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzniczak, Ewa, Otto, Oliver, Whyte, Graeme, Chandra, Tamir, Robertson, Neil A., Willoughby, Nik, Jimenez, Melanie, Bridle, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383897/
https://www.ncbi.nlm.nih.gov/pubmed/32100873
http://dx.doi.org/10.1002/bit.27319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383897/
https://www.ncbi.nlm.nih.gov/pubmed/32100873
http://dx.doi.org/10.1002/bit.27319

Ejemplares similares